血管閉鎖装置の2030年までの市場予測：製品別、アクセスモード別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、血管閉鎖装置の世界市場は2024年に13億米ドルを占め、予測期間中にCAGR 8.3％で成長し、2030年には21億米ドルに達する見込みです。

血管閉鎖器具（VCD）は、血管の穿刺を密封または閉鎖するように設計された医療器具であり、通常、血管造影や経皮的冠動脈インターベンションのようなカテーテルを用いた処置の後に使用されます。これらの器具は、出血を最小限に抑え、合併症を減少させ、穿刺部位の止血を早めることで回復を早めるために極めて重要です。VCDは、機械的圧迫、組織接着剤、特殊なプラグやパッチの配備など、さまざまなメカニズムで作動します。血管の入り口を効果的に塞ぐことで、VCDは血腫、出血、感染症などの合併症を防ぎ、患者が通常の活動をより早く再開できるようにします。

英国心臓財団によると、2024年には世界中で約6億2,000万人が心臓や循環器系の疾患を抱えて生活しています。メディケア・メディケイド・サービスセンター（CMS.gov）のデータによると、2023年、米国は医療費に約4兆7,000億米ドルを費やし、国民経済の18％を占めています。

低侵襲治療への嗜好の高まり

低侵襲手技への嗜好の高まりは、血管閉鎖装置（VCD）の進歩を促しています。VCDは、カテーテルを用いたインターベンション後にアクセス部位を効率的に閉鎖するために極めて重要です。ヘルスケアが患者の回復時間を短縮し、合併症を最小限に抑えるために侵襲の少ない手技へとシフトする中、VCDはこうした要求に応えるべく進化しています。最新のVCDは、バスキュラーアクセスポイントの迅速かつ確実な閉鎖を確実にするために、先進的な材料と技術を使用することにより、安全性、有効性、患者の快適性を向上させています。この動向は、より小さな切開、より少ない痛み、より迅速な通常の活動への復帰を伴う手技を目指す医療における広範な動きを反映しています。

臨床上のリスクと合併症

血管閉鎖装置（VCD）は、カテーテルを用いた手技の後に大腿動脈のアクセス部位を閉鎖するように設計されており、出血を最小限に抑え、回復を早めることを目的としています。VCDの使用には、その有効性を妨げる臨床的リスクと合併症が伴います。主なリスクとしては、感染、血腫形成、血管損傷などがあり、これらは四肢の虚血や血栓症などの合併症を引き起こす可能性があります。また、出血や動脈損傷を引き起こす可能性のある不十分なシーリングやデバイスの移動など、デバイスに関連した問題の可能性もあります。

心血管系処置の増加

血管形成術やステント留置などの手技の増加に伴い、効率的で安全かつ効果的なVCDの需要が急増しています。最新のVCDは迅速な止血、出血や感染などの合併症の軽減、回復時間の短縮を目的として設計されています。VCD技術の革新には、より優れた組織密封のための素材の改良、臨床医にとっての使いやすさの向上、さまざまな血管アクセス部位に対応するデザインなどが含まれます。これらの進歩は、患者の回復を早めるだけでなく、手技の効率を高め、心血管インターベンションの複雑化と頻度の増加に対応しています。

知的財産の課題

血管閉鎖装置（VCD）業界は、知的財産（IP）問題による大きな課題に直面しています。特許紛争や制限的な知的財産権の主張は、新規参入企業による独自のデバイスの開発や販売を妨げ、イノベーションを阻害する可能性があります。既存の企業は、基本的な技術をカバーする広範な特許を保有していることが多く、新興企業やその他の競合他社に障壁を作り出しています。このような状況は、高額な法廷闘争につながり、研究開発からリソースをそらすことになります。厳しい知的財産権規制は、より優れた可能性のある新しい機器の市場導入を遅らせ、患者ケアの進歩を制限する可能性があります。その結果、市場は制約を受け、技術革新は遅れ、医療機器のコストは高止まりし、患者へのアクセスや治療の選択肢に影響を与えることになります。

COVID-19の影響：

COVID-19の大流行は、選択的処置の中断とヘルスケアの優先順位の変化により、血管閉鎖器具（VCD）市場に大きな影響を与えました。世界中の病院が重篤なCOVID-19症例の管理に集中したため、バスキュラーアクセスを必要とする処置を含む緊急性のない処置の多くが延期または中止されました。このため、カテーテルを用いた処置の後に動脈アクセス部位を閉鎖するために使用されるVCDの需要が一時的に減少しました。サプライチェーンの混乱や制限は、これらの器具の生産や流通に影響を与えました。パンデミックはまた、遠隔で侵襲の少ない診断技術の採用を加速させ、VCDの従来の使用法にさらに影響を与えました。

予測期間中、アクティブ近似器セグメントが最大になる見込み

予測期間中、アクティブ近似器分野が最大となる見込みです。アクティブ近似器は、その有効性と使いやすさを大幅に改善することで、血管閉鎖装置に革命をもたらしています。これらの先進的なデバイスは、カテーテル治療後に残された穿刺部位を確実に閉鎖するために動的なメカニズムを利用しています。静的な圧力や手動操作に依存する従来の受動的な方法とは異なり、能動的な近似器は制御された調節可能な力を加え、血管の開口部を正確に整列させて密閉します。この技術革新により、出血や感染などの合併症を最小限に抑えながら、信頼性の高い閉鎖を達成することができます。

予測期間中、脳血管インターベンション分野のCAGRが最も高くなる見込み

予測期間中、脳血管インターベンション分野のCAGRが最も高くなると予想されます。脳血管インターベンション分野は、血管閉鎖の精度を高め、合併症発生率を低減し、回復時間を短縮することに重点を置いています。最新のVCDは、止血剤の改良や適応性の高い閉鎖機構といった革新的な機能を備えており、アクセス部位の密閉性を高め、周辺組織への外傷を最小限に抑えます。さらに、リアルタイム画像や高度な追跡システムを組み込むことで、より正確なデバイスの配置とモニタリングが可能になります。

最大のシェアを占める地域

欧州地域は、最先端技術の統合、医療トレーニングの向上、規制プロセスの合理化などにより、予測期間を通じて最大の市場シェアを占めています。カテーテル治療などの処置後に動脈穿刺を密封するのに重要な先進的VCDは、同地域全体でヘルスケア施設や研究への投資が増加しています。インフラが強化されたことで、より高い精度、安全性、患者の快適性を提供する革新的なデバイスの開発と展開が地域全体で促進されています。最先端のツールや設備を備えた病院やクリニックは、これらの先進的なVCDをより効果的に活用することができ、手技結果の改善や回復時間の短縮につながります。これらの要素が地域の成長を後押ししています。

CAGRが最も高い地域：

欧州地域は、厳格な安全性と有効性基準を確保することによる血管閉鎖装置（VCDs）の採用により、予測期間中に大幅な成長が見られると予測されています。医療機器規制（MDR）や体外診断用医薬品規制（IVDR）を含む欧州連合の規制枠組みは、これらの機器に対して厳格な臨床評価、品質管理対策、市販後サーベイランスを義務付けています。このような規制による監視は、メーカーに高い基準の遵守を促すことで技術革新を促進し、地域全体で技術の進歩と患者の転帰の改善を促しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の血管閉鎖装置市場：製品別

• パッシブ近似器
• アクティブ近似器
• 外部止血装置

第6章 世界の血管閉鎖装置市場：アクセスモード別

• 大腿部アクセス
• ラジアルアクセス

第7章 世界の血管閉鎖装置市場：用途別

• 末梢血管介入
• 脳血管介入
• その他の用途

第8章 世界の血管閉鎖装置市場：エンドユーザー別

• 病院
• 心臓カテーテル検査室
• その他のエンドユーザー

第9章 世界の血管閉鎖装置市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイリング

• Abbott Laboratories
• Boston Scientific Corporation
• Cardinal Health, Inc
• Endologix, Inc
• GE Healthcare
• HeartWare International, Inc
• Medtronic PLC
• Nipro Corporation
• Stryker Corporation
• Terumo Corporation

List of Tables

• Table 1 Global Vascular Closure Devices Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
• Table 3 Global Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
• Table 4 Global Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
• Table 5 Global Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
• Table 6 Global Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
• Table 7 Global Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
• Table 8 Global Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
• Table 9 Global Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
• Table 10 Global Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
• Table 11 Global Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
• Table 12 Global Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 13 Global Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
• Table 14 Global Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 15 Global Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
• Table 16 Global Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 17 North America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
• Table 18 North America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
• Table 19 North America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
• Table 20 North America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
• Table 21 North America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
• Table 22 North America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
• Table 23 North America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
• Table 24 North America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
• Table 25 North America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
• Table 26 North America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
• Table 27 North America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
• Table 28 North America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 29 North America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
• Table 30 North America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 31 North America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
• Table 32 North America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 33 Europe Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
• Table 34 Europe Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
• Table 35 Europe Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
• Table 36 Europe Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
• Table 37 Europe Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
• Table 38 Europe Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
• Table 39 Europe Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
• Table 40 Europe Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
• Table 41 Europe Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
• Table 42 Europe Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
• Table 43 Europe Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
• Table 44 Europe Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 45 Europe Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
• Table 46 Europe Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 47 Europe Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
• Table 48 Europe Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 49 Asia Pacific Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
• Table 50 Asia Pacific Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
• Table 51 Asia Pacific Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
• Table 52 Asia Pacific Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
• Table 53 Asia Pacific Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
• Table 54 Asia Pacific Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
• Table 55 Asia Pacific Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
• Table 56 Asia Pacific Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
• Table 57 Asia Pacific Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
• Table 58 Asia Pacific Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
• Table 59 Asia Pacific Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
• Table 60 Asia Pacific Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 61 Asia Pacific Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
• Table 62 Asia Pacific Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 63 Asia Pacific Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
• Table 64 Asia Pacific Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 65 South America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
• Table 66 South America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
• Table 67 South America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
• Table 68 South America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
• Table 69 South America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
• Table 70 South America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
• Table 71 South America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
• Table 72 South America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
• Table 73 South America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
• Table 74 South America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
• Table 75 South America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
• Table 76 South America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 77 South America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
• Table 78 South America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 79 South America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
• Table 80 South America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 81 Middle East & Africa Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
• Table 82 Middle East & Africa Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
• Table 83 Middle East & Africa Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
• Table 84 Middle East & Africa Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
• Table 85 Middle East & Africa Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
• Table 86 Middle East & Africa Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
• Table 87 Middle East & Africa Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
• Table 88 Middle East & Africa Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
• Table 89 Middle East & Africa Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
• Table 90 Middle East & Africa Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
• Table 91 Middle East & Africa Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
• Table 92 Middle East & Africa Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 93 Middle East & Africa Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
• Table 94 Middle East & Africa Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 95 Middle East & Africa Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
• Table 96 Middle East & Africa Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)

According to Stratistics MRC, the Global Vascular Closure Devices Market is accounted for $1.3 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Vascular closure devices (VCDs) are medical instruments designed to seal or close punctures in blood vessels, typically following catheter-based procedures like angiography or percutaneous coronary interventions. These devices are crucial for minimizing bleeding, reducing complications, and expediting recovery by facilitating faster hemostasis at the puncture site. VCDs operate through various mechanisms, including mechanical compression, tissue adhesives, or the deployment of specialized plugs or patches. By effectively sealing the vascular entry point, VCDs help prevent complications such as hematomas, bleeding, or infections, and allow patients to resume normal activities more quickly.

According to the British Heart Foundation, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. According to the data by Centers for Medicare and Medicaid Services (CMS.gov) shows that in 2023, the U.S. spent approximately USD 4.7 trillion on healthcare, constituting 18% of the national economy.

Market Dynamics:

Driver:

Growing preference for minimally invasive procedures

The increasing preference for minimally invasive procedures is driving advancements in Vascular Closure Devices (VCDs), which are crucial for efficiently closing access sites after catheter-based interventions. As healthcare shifts towards less invasive techniques to reduce patient recovery times and minimize complications, VCDs are evolving to meet these demands. Modern VCDs offer improved safety, efficacy, and patient comfort by using advanced materials and technologies to ensure rapid and secure closure of vascular access points. This trend reflects a broader movement in medicine towards procedures that involve smaller incisions, less pain, and quicker returns to normal activities.

Restraint:

Clinical risks and complications

Vascular Closure Devices (VCDs) are designed to close femoral artery access sites after catheter-based procedures, aiming to minimize bleeding and expedite recovery. Their use carries clinical risks and complications that can impede their effectiveness. Key risks include infection, hematoma formation, and vascular injury, which can lead to complications like limb ischemia or thrombosis. There is also the potential for device-related issues such as inadequate sealing or device migration, which can cause bleeding or arterial damage.

Opportunity:

Rise in cardiovascular procedures

As the volume of procedures like angioplasty and stent placements rises, the demand for efficient, safe, and effective VCDs has surged. Modern VCDs are designed to provide faster hemostasis, reduce complications such as bleeding and infection, and shorten recovery times. Innovations in VCD technology include improved materials for better tissue sealing, enhanced ease of use for clinicians, and designs that accommodate various vascular access sites. These advancements not only facilitate quicker patient recovery but also enhance procedural efficiency, aligning with the growing complexity and frequency of cardiovascular interventions.

Threat:

Intellectual property challenges

The vascular closure device (VCD) industry faces significant challenges due to intellectual property (IP) issues. Patent disputes and restrictive IP claims can stifle innovation by preventing new entrants from developing or marketing their own devices. Established companies often hold broad patents that cover fundamental technologies, creating barriers for startups and other competitors. This situation can lead to expensive legal battles, which divert resources away from research and development. Stringent IP regulations can delay the introduction of new, potentially better devices to the market, limiting advancements in patient care. The result is a constrained market where innovation is slowed, and the cost of devices may remain high, impacting accessibility and treatment options for patients.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the vascular closure devices (VCDs) market due to disruptions in elective procedures and a shift in healthcare priorities. As hospitals worldwide focused on managing severe COVID-19 cases, many non-urgent procedures, including those requiring vascular access, were postponed or canceled. This led to a temporary decline in demand for VCDs, which are used to close the arterial access site after catheter-based procedures. Supply chain disruptions and restrictions affected the production and distribution of these devices. The pandemic also accelerated the adoption of remote and less invasive diagnostic techniques, further impacting the traditional usage of VCDs.

The Active Approximators segment is expected to be the largest during the forecast period

Active Approximators segment is expected to be the largest during the forecast period. Active approximators are revolutionizing vascular closure devices by significantly improving their efficacy and ease of use. These advanced devices utilize dynamic mechanisms to securely close the puncture site left after catheterization procedures. Unlike traditional passive methods that rely on static pressure or manual manipulation, active approximators apply controlled, adjustable forces to precisely align and seal the vascular opening. This innovation enhances the device's ability to achieve a reliable closure with minimal complications, such as bleeding or infection.

The Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period

Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period. Cerebrovascular Interventions segment focus on increasing the precision of vascular closure, reducing complication rates, and shortening recovery times. Modern VCDs are designed with innovative features such as improved hemostatic agents and more adaptable closure mechanisms, which ensure better sealing of the access site and minimal trauma to surrounding tissues. Additionally, the incorporation of real-time imaging and advanced tracking systems allows for more accurate device placement and monitoring.

Region with largest share:

Europe region commanded the largest market share over the extrapolated period driven by the integration of cutting-edge technologies, improved medical training, and streamlined regulatory processes. Advanced VCDs, which are crucial for sealing arterial punctures after procedures like catheterizations, are benefiting from increased investment in healthcare facilities and research across the region. Enhanced infrastructure facilitates the development and deployment of innovative devices that offer greater precision, safety, and patient comfort throughout the region. Hospitals and clinics equipped with state-of-the-art tools and facilities can more effectively utilize these advanced VCDs, leading to improved procedural outcomes and reduced recovery times. These elements are boosting the regional growth.

Region with highest CAGR:

Europe region is projected to witness substantial growth during the forecast period due to the adoption of Vascular Closure Devices (VCDs) by ensuring stringent safety and efficacy standards. The European Union's regulatory framework, including the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), mandates rigorous clinical evaluations, quality control measures, and post-market surveillance for these devices. This regulatory oversight fosters innovation by encouraging manufacturers to adhere to high standards, thus driving advancements in technology and improving patient outcomes across the region.

Key players in the market

Some of the key players in Vascular Closure Devices market include Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc, Endologix, Inc, GE Healthcare, HeartWare International, Inc, Medtronic PLC, Nipro Corporation, Stryker Corporation and Terumo Corporation.

Key Developments:

In June 2024, Haemonetics Corporation has announced the launch of its new VASCADE MVP XL mid-bore venous closure device. The VASCADE MVP XL system adds to Haemonetics VASCADE line of vascular closure devices by using novel collapsible disc technology with a patented resorbable collagen patch that promotes fast hemostasis.

In November 2023, Johnson & Johnson Service Inc., a biotechnology company, announced the completion of the acquisition of Laminar, Inc., a privately held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).

In February 2023, the LockeT product was introduced to the market by Catheter Precision, Inc., a wholly-owned subsidiary of Ra Medical Systems, Inc. The first shipments of the product to its distributors will start right away. When a catheter is inserted through the skin into a blood artery and subsequently removed after an operation, LockeT can be utilized in combination with the closure of the percutaneous wound site.

Products Covered:

• Passive Approximators
• Active Approximators
• External Haemostatic Devices

Access Modes Covered:

• Femoral Access
• Radial Access

Applications Covered:

• Peripheral Vascular Interventions
• Cerebrovascular Interventions
• Other Applications

End Users Covered:

• Hospitals
• Cardiac Catheterization Laboratories
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Vascular Closure Devices Market, By Product

• 5.1 Introduction
• 5.2 Passive Approximators
• 5.3 Active Approximators
• 5.4 External Haemostatic Devices

6 Global Vascular Closure Devices Market, By Access Mode

• 6.1 Introduction
• 6.2 Femoral Access
• 6.3 Radial Access

7 Global Vascular Closure Devices Market, By Application

• 7.1 Introduction
• 7.2 Peripheral Vascular Interventions
• 7.3 Cerebrovascular Interventions
• 7.4 Other Applications

8 Global Vascular Closure Devices Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Cardiac Catheterization Laboratories
• 8.4 Other End Users

9 Global Vascular Closure Devices Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Abbott Laboratories
• 11.2 Boston Scientific Corporation
• 11.3 Cardinal Health, Inc
• 11.4 Endologix, Inc
• 11.5 GE Healthcare
• 11.6 HeartWare International, Inc
• 11.7 Medtronic PLC
• 11.8 Nipro Corporation
• 11.9 Stryker Corporation
• 11.10 Terumo Corporation